Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 4
1949 14
1950 32
1951 10
1952 13
1953 7
1954 13
1955 9
1956 10
1957 11
1958 9
1959 11
1960 9
1961 5
1962 15
1963 29
1964 42
1965 32
1966 24
1967 28
1968 36
1969 39
1970 19
1971 57
1972 42
1973 40
1974 63
1975 54
1976 41
1977 40
1978 37
1979 38
1980 43
1981 56
1982 47
1983 57
1984 61
1985 85
1986 109
1987 101
1988 83
1989 119
1990 137
1991 141
1992 145
1993 135
1994 113
1995 122
1996 115
1997 113
1998 127
1999 108
2000 90
2001 92
2002 103
2003 88
2004 81
2005 92
2006 104
2007 124
2008 127
2009 124
2010 133
2011 145
2012 151
2013 149
2014 132
2015 121
2016 138
2017 122
2018 101
2019 92
2020 109
2021 95
2022 91
2023 103
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

5,271 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin C and D supplementation in acute myeloid leukemia.
Mouchel PL, Bérard E, Tavitian S, Gadaud N, Vergez F, Rieu JB, Luquet I, Sarry A, Huguet F, Largeaud L, Delabesse E, Huynh A, Bertoli S, Récher C. Mouchel PL, et al. Blood Adv. 2023 Nov 28;7(22):6886-6897. doi: 10.1182/bloodadvances.2023010559. Blood Adv. 2023. PMID: 37671973 Free PMC article.
Recent studies have highlighted the role of vitamin C and D in acute myeloid leukemia (AML). In 2018, we changed our practices to add both vitamins to the supportive care for all consecutive patients with AML undergoing intensive chemotherapy. ...Most patient …
Recent studies have highlighted the role of vitamin C and D in acute myeloid leukemia (AML). In 2018, we changed our practices …
Application of vitamin D and vitamin D analogs in acute myelogenous leukemia.
Cao H, Xu Y, de Necochea-Campion R, Baylink DJ, Payne KJ, Tang X, Ratanatharathorn C, Ji Y, Mirshahidi S, Chen CS. Cao H, et al. Exp Hematol. 2017 Jun;50:1-12. doi: 10.1016/j.exphem.2017.01.007. Epub 2017 Feb 4. Exp Hematol. 2017. PMID: 28174131 Free article. Review.
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant, transformed immature hematopoietic myeloid precursors that have lost their ability to differentiate and proliferate normally. ...Studies have shown that 1alpha,25-dihydroxyvitamin D3 (1,25-D3, …
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant, transformed immature hematopoietic myeloid precursors …
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Abdel-Wahab O, Park CY, Tsirigos A, Neel BG, Aifantis I. Cimmino L, et al. Cell. 2017 Sep 7;170(6):1079-1095.e20. doi: 10.1016/j.cell.2017.07.032. Epub 2017 Aug 17. Cell. 2017. PMID: 28823558 Free PMC article.
Vitamin C also drives DNA hypomethylation and expression of a TET2-dependent gene signature in human leukemia cell lines. Furthermore, TET-mediated DNA oxidation induced by vitamin C treatment in leukemia cells enhances their sensitivity to PARP inhibi
Vitamin C also drives DNA hypomethylation and expression of a TET2-dependent gene signature in human leukemia cell lines. Furt
Vitamin B12: For more than just the treatment of megaloblastic anemia?
Pardo-Cabello AJ, Manzano-Gamero V, Puche-Cañas E. Pardo-Cabello AJ, et al. Rev Clin Esp (Barc). 2023 Feb;223(2):114-119. doi: 10.1016/j.rceng.2022.11.004. Epub 2023 Jan 18. Rev Clin Esp (Barc). 2023. PMID: 36669740 Review.
Vitamin B12, or cobalamin, belongs to the group of water-soluble vitamins and is ingested through food of animal origin such as eggs, milk, red meat and poultry, fish, and shellfish. ...Hypervitaminosis B12 has been associated with renal failure; liver diseases such
Vitamin B12, or cobalamin, belongs to the group of water-soluble vitamins and is ingested through food of animal origin such a
Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D.
James SY, Williams MA, Newland AC, Colston KW. James SY, et al. Gen Pharmacol. 1999 Jan;32(1):143-54. doi: 10.1016/s0306-3623(98)00098-6. Gen Pharmacol. 1999. PMID: 9888267 Review.
In addition, some leukemia cells develop resistance to chemotherapy and are therefore difficult to eradicate. 2. ...Cellular studies have revealed that combinations of vitamin D derivatives and retinoids such as ATRA and 9-cis retinoic acid (9-cis RA) exhibit cooper …
In addition, some leukemia cells develop resistance to chemotherapy and are therefore difficult to eradicate. 2. ...Cellular studies …
The role of cadmium in the pathogenesis of myeloid leukemia in individuals with anemia, deficiencies in vitamin D, zinc, and low calcium dietary intake.
Djulejic V, Petrovic B, Jevtic J, Vujacic M, Clarke BL, Cirovic A, Cirovic A. Djulejic V, et al. J Trace Elem Med Biol. 2023 Sep;79:127263. doi: 10.1016/j.jtemb.2023.127263. Epub 2023 Jul 16. J Trace Elem Med Biol. 2023. PMID: 37499549 Review.
Iron deficiency, vitamin D deficiency and low calcium diet are frequent health problems with severe long- term consequences. ...We speculate that the final event in the case of low calcium dietary diet and/or vitamin D deficiency is similar to what is observed in th …
Iron deficiency, vitamin D deficiency and low calcium diet are frequent health problems with severe long- term consequences. ...We sp …
Vitamin D status in children with leukemia, its predictors, and association with outcome.
Jackmann N, Mäkitie O, Harila-Saari A, Gustafsson J, Nezirevic Dernroth D, Frisk P. Jackmann N, et al. Pediatr Blood Cancer. 2020 Apr;67(4):e28163. doi: 10.1002/pbc.28163. Epub 2020 Jan 11. Pediatr Blood Cancer. 2020. PMID: 31925904
BACKGROUND: Children and adolescents with leukemia are potentially at high risk of vitamin D inadequacy, which may have clinical relevance for skeletal morbidity, infections, and cancer outcome. This study aimed to evaluate vitamin D status at the time of dia …
BACKGROUND: Children and adolescents with leukemia are potentially at high risk of vitamin D inadequacy, which may have clinic …
Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study.
Solmaz I, Ozdemir MA, Unal E, Abdurrezzak U, Muhtaroglu S, Karakukcu M. Solmaz I, et al. J Pediatr Endocrinol Metab. 2021 Feb 25;34(4):441-447. doi: 10.1515/jpem-2020-0637. Print 2021 Apr 27. J Pediatr Endocrinol Metab. 2021. PMID: 33639045 Clinical Trial.
As osteoporosis is a frequent complication in patients under chemotherapy, we investigated the effect of vitamin K2 (100 mcg menaquinone-7) and vitamin D3 (10 mcg calcitriol) on bone metabolism in children with ALL. ...CONCLUSIONS: These results suggest an early ben …
As osteoporosis is a frequent complication in patients under chemotherapy, we investigated the effect of vitamin K2 (100 mcg menaquin …
The neurotoxic effects of vitamin A and retinoids.
Oliveira MR. Oliveira MR. An Acad Bras Cienc. 2015 Aug;87(2 Suppl):1361-73. doi: 10.1590/0001-3765201520140677. Epub 2015 Aug 4. An Acad Bras Cienc. 2015. PMID: 26247148 Free article. Review.
Furthermore, such molecules may be applied as therapeutic agents in the case of some diseases, including dermatological disturbances, immunodeficiency, and cancer (mainly leukemia). In spite of this, there is a growing body of evidences showing that vitamin A doses …
Furthermore, such molecules may be applied as therapeutic agents in the case of some diseases, including dermatological disturbances, immuno …
Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells.
Okabe S, Gotoh A. Okabe S, et al. BMC Cancer. 2023 Sep 5;23(1):827. doi: 10.1186/s12885-023-11304-4. BMC Cancer. 2023. PMID: 37670241 Free PMC article.
BACKGROUND: Abelson (ABL) tyrosine kinase inhibitors (TKIs) are effective against chronic myeloid leukemia (CML); however, many patients develop resistance during ABL TKI therapy. Vitamin K2 (VK2) is a crucial fat-soluble vitamin used to activate hepatic coag …
BACKGROUND: Abelson (ABL) tyrosine kinase inhibitors (TKIs) are effective against chronic myeloid leukemia (CML); however, many patie …
5,271 results